Zydus Healthcare gets CDSCO Panel nod to conduct Phase III CT of Glycopyrrolate plus Indacaterol Metered Dose Inhalation Dr. Divya Colin13 April 2025 6:15 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organization (CDSCO), has granted approval to Zydus...
Conduct Phase III CT: CDSCO Panel Tells Zydus Healthcare on Glycopyrrolatem plus Indacaterol metered dose inhalation Dr. Divya Colin24 Nov 2024 5:30 PM ISTNew Delhi: Considering the bioequivalence study report presented by Zydus Healthcare, the Subject Expert Committee (SEC) functional under the Central...
Conduct bioequivalence study: CDSCO Panel tells Zydus Healthcare on Glycopyrrolate, Indacaterol Metered dose inhalation Dr. Divya Colin22 Dec 2023 6:00 PM ISTNew Delhi: Rejecting the clinical trial waiver proposal, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Conduct bioequivalence study: CDSCO Panel Tells Lupin on FDC Indacaterol, Glycopyrronium inhalation powder Dr. Divya Colin28 Nov 2023 6:00 PM ISTNew Delhi: Rejecting the justification for the waiver of the bioequivalence study (BE) and Phase III clinical study of fixed-dose combination (FDC)...
Glenmark Gets CDSCO Panel Nod to study Indacaterol, Glycopyrrolate,Mometasone Furoate FDC drug Dr. Divya Colin23 July 2023 6:00 PM ISTNew Delhi: The drug major Glenmark has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Glenmark gets CDSCO panel nod to manufacture ,market pulmonary FDC drug Dr. Divya Colin10 April 2023 6:00 PM ISTNew Delhi: The drug major Glenmark has got the go ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Lupin unveils fixed-dose triple drug combination DIFIZMA DPI for inadequately controlled asthma Ruchika Sharma6 Jan 2023 11:38 AM IST"DIFIZMA is the only FDC that has been approved by the Drug Controller General of India (DCGI) for the treatment of inadequately controlled Asthma,"...
Zydus Healthcare gets CDSCO panel nod to manufacture, market Indacaterol, Budesonide Inhaler Susmita Roy4 Oct 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Zydus Healthcare has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Health Bulletin 17/June/2022 Roshni Dhar17 Jun 2022 4:52 PM ISTHere are the top health stories for the day:Delhi reports 1,323 fresh Covid-19 infections on Thursday More than 1,323 new...
Glenmark unveils FDC drug for Asthma in India Ruchika Sharma16 Jun 2022 11:40 AM ISTIndamet will help in the management of uncontrolled asthma by improving lung function, better symptom control and reducing exacerbations.
Glenmark gets CDSCO panel nod to manufacture and market COPD drug Dr. Divya Colin9 May 2022 6:52 PM ISTNew Delhi: Based on the justification provided by the pharmaceutical major Glenmark pharmaceuticals, the Subject Expert Committee (SEC) of the Central...
Conduct clinical trial in Indian patient: CDSCO panel tells Glenmark on pulmonary drug study Medical Dialogues Team17 Dec 2021 6:43 PM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has directed Glenmark to conduct a Phase 3...
